TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10463321

Group type: EXPERIMENTAL
Intervention: Intravenous ketamine infusion (bolus of 0.26 mg/kg followed by 0.65 mg/kg per hour) with oral haloperidol 5 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intravenous ketamine infusion (bolus of 0.26 mg/kg followed by 0.65 mg/kg per hour) with matched placebo
Number of subjects: 20
Study: 8667595

Group type: EXPERIMENTAL
Intervention: Antineoplaston A-10 oral formulation (14 patients)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Antineoplaston A-10 injectable formulation (25 patients)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Antineoplaston AS2-1 oral formulation (33 patients)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Antineoplaston AS2-1 injectable formulation (10 patients)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Combination therapy with Antineoplastons
Number of subjects: 42
Study: 2628135

Group type: EXPERIMENTAL
Intervention: Gastrectomy with Roux-en-Y diversion
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Gastrectomy with Billroth II reconstruction
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Postoperative follow-up (6 months)
Number of subjects: 22
Study: 841647

Group type: EXPERIMENTAL
Intervention: BCG vaccination (intrademal injection)
Number of subjects: 8856

Group type: EXPERIMENTAL
Intervention: Initial tuberculin reaction of 4 mm or greater
Number of subjects: 8856

Group type: EXPERIMENTAL
Intervention: BCG vaccinated group
Number of subjects: 8856

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 8856
Study: 31043169

Group type: EXPERIMENTAL
Intervention: Initial assessment by physiotherapists
Number of subjects: 55

Group type: COMPARATOR
Intervention: Standard practice with initial GP assessment
Number of subjects: 55
Study: 27121863

Group type: EXPERIMENTAL
Intervention: Relaxation training
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 50
Study: 25283137

Group type: EXPERIMENTAL
Intervention: 1 g of chloral hydrate (CH) for five consecutive days
Number of subjects: 8

Group type: COMPARATOR
Intervention: 1.5 μg/kg of chloral hydrate (CH) for five consecutive days (environmental dose)
Number of subjects: 8
Study: 23348836

Group type: EXPERIMENTAL
Intervention: Topical 5-fluorouracil
Number of subjects: 1131

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers
Number of subjects: 1131

Group type: COMPARATOR
Intervention: None (control group)
Number of subjects: 1131
Study: 20797824

Group type: EXPERIMENTAL
Intervention: Short neoadjuvant hormonal therapy (4 months; Arm 1)
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Long neoadjuvant hormonal therapy (8 months; Arm 2)
Number of subjects: 261
Study: 19247758

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided block of the brachial plexus using lidocaine 1.5% with epinephrine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided block of the brachial plexus
Number of subjects: 20
Study: 16890660

Group type: EXPERIMENTAL
Intervention: Ofloxacin (200 mg) with bacillus Calmette‐Guerin
Number of subjects: 115

Group type: COMPARATOR
Intervention: Bacillus Calmette‐Guerin (placebo)
Number of subjects: 115
Study: 15301635

Group type: EXPERIMENTAL
Intervention: Methylphenidate 5 mg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Methylphenidate 10 mg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Methylphenidate 20 mg
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 11165973

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 130

Group type: COMPARATOR
Intervention: Atorvastatin
Number of subjects: 130
Study: 9407567

Group type: EXPERIMENTAL
Intervention: Exosurf
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Survanta
Number of subjects: 16
Study: 7970086

Group type: EXPERIMENTAL
Intervention: Aspirin plus dipyridamole
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (protein restriction, antihypertensive therapy)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Comparison of treatment vs control
Number of subjects: 18
Study: 2451494

Group type: EXPERIMENTAL
Intervention: 0.1% sodium hyaluronate artificial tear preparation
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1.4% polyvinyl alcohol and 0.5% chlorobutanol artificial tear preparation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both preparations
Number of subjects: 0
Study: 31702992

Group type: EXPERIMENTAL
Intervention: Anodal high-voltage monophasic pulsed currents (HVMPC) treatment (154 μs; 100 Hz; 360 µC/sec; 1.08 C/day) for 50 minutes a day, 5 days per week, for 8 weeks.
Number of subjects: 43

Group type: COMPARATOR
Intervention: Cathodal high-voltage monophasic pulsed currents (HVMPC) treatment (154 μs; 100 Hz; 360 µC/sec; 1.08 C/day) for 50 minutes a day, 5 days per week, for 8 weeks.
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo (sham) treatment for 50 minutes a day, 5 days per week, for 8 weeks.
Number of subjects: 43
Study: 28445474

Group type: EXPERIMENTAL
Intervention: COACH program (medication reconciliation, patient counselling at discharge, communication to healthcare providers)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: COACH program
Number of subjects: 319

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 319
Study: 26007320

Group type: EXPERIMENTAL
Intervention: Condori red grapes (500 g daily for 8 weeks)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Shahroodi white grapes (500 g daily for 8 weeks)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (no grape consumption)
Number of subjects: 69
Study: 24001950

Group type: EXPERIMENTAL
Intervention: G-Bond (self-etching adhesive)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: cfm (3-step HEMA and TEGDMA free etch-and-rinse)
Number of subjects: 67

Group type: COMPARATOR
Intervention: XP Bond (control HEMA-containing etch-and-rinse adhesive)
Number of subjects: 67
Study: 20951420

Group type: EXPERIMENTAL
Intervention: Flowable composite lining
Number of subjects: 80

Group type: COMPARATOR
Intervention: Glass-ionomer lining
Number of subjects: 80

Group type: COMPARATOR
Intervention: Unlined
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cavity width and C-factor
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cavity depth and cusp compliance
Number of subjects: 80
Study: 19934458

Group type: EXPERIMENTAL
Intervention: SHIP-DM intervention (6-week structured psychobehavioral education, home glucose monitoring with teletransmission, bilingual nurse telephone counseling for 24 weeks)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (delayed intervention design)
Number of subjects: 79
Study: 21959045

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus mIFL (irinotecan 125 mg/m², leucovorin 20 mg/m² bolus, 5-fluorouracil 500 mg/m² weekly for four weeks every six weeks)
Number of subjects: 214

Group type: COMPARATOR
Intervention: mIFL (irinotecan 125 mg/m², leucovorin 20 mg/m² bolus, 5-fluorouracil 500 mg/m² weekly for four weeks every six weeks)
Number of subjects: 214
Study: 16156464

Group type: EXPERIMENTAL
Intervention: Cemented fixation (C-F)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Uncemented porous fixation (UC-F)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Uncemented porous hydroxyapatite fixation (UCHA-F)
Number of subjects: 116
Study: 12484510

Group type: EXPERIMENTAL
Intervention: Benazepril 5 mg daily (normal dose) in patients with LVH
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Benazepril 2.5 mg daily (half dose) in patients without LVH
Number of subjects: 72

Group type: COMPARATOR
Intervention: Discontinuation of ACE inhibitor in patients with or without LVH
Number of subjects: 72
Study: 9771173

Group type: EXPERIMENTAL
Intervention: Isoflurane delivered from a Komesaroff vaporiser
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Fresh gas flow rates of 1, 2 or 3 l.min‐1
Number of subjects: 19
Study: 8580391

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg daily)
Number of subjects: 671

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 671
Study: 2653592

Group type: EXPERIMENTAL
Intervention: 0.5% levobunolol hydrochloride
Number of subjects: 91

Group type: COMPARATOR
Intervention: 0.5% timolol maleate
Number of subjects: 91
Study: 383097

Group type: EXPERIMENTAL
Intervention: 3 times a day 3 mg haloperidol (3-day group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 9 mg haloperidol only in the evening (1-day group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 30
Study: 11312480

Group type: COMPARATOR
Intervention: Control (no antiarrhythmics)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Magnesium only
Number of subjects: 400

Group type: COMPARATOR
Intervention: Digoxin only
Number of subjects: 400

Group type: COMPARATOR
Intervention: Magnesium and digoxin
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Propranolol only
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Magnesium and propranolol
Number of subjects: 400
Study: 31392827

Group type: EXPERIMENTAL
Intervention: Betrixaban 80 mg qd for 35 to 42 days
Number of subjects: 2781

Group type: COMPARATOR
Intervention: Enoxaparin 40 mg qd for 10 ± 4 days
Number of subjects: 2781
Study: 30293126

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 15 mg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Warfarin (dose-adjusted)
Number of subjects: 0
Study: 27060958

Group type: EXPERIMENTAL
Intervention: Multisensory Stimulation Environment (MSSE)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Individualized Music Sessions
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both MSSE and Individualized Music Sessions
Number of subjects: 22
Study: 25268099

Group type: EXPERIMENTAL
Intervention: Continuous renal replacement therapy (CRRT)
Number of subjects: 54
Study: 23170921

Group type: EXPERIMENTAL
Intervention: Alfentanil, midazolam and propofol
Number of subjects: 260

Group type: COMPARATOR
Intervention: Fentanyl, midazolam and propofol
Number of subjects: 260
Study: 20022809

Group type: EXPERIMENTAL
Intervention: Gefitinib (250 mg/day orally)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Cisplatin (80 mg/m2 intravenously) plus Docetaxel (60 mg/m2 intravenously)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Gefitinib
Number of subjects: 172
Study: 17710370

Group type: EXPERIMENTAL
Intervention: MMRV vaccine (GlaxoSmithKline Biologicals)
Number of subjects: 299

Group type: COMPARATOR
Intervention: MMR+V (Priorix and Varilrix vaccines)
Number of subjects: 299
Study: 14713758

Group type: EXPERIMENTAL
Intervention: Chemoprevention agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phase 2 clinical trials of various agents
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prostate Cancer Prevention Trial
Number of subjects: 0

Group type: COMPARATOR
Intervention: Selenium and Vitamin E Cancer Prevention Trial
Number of subjects: 0
Study: 11781276

Group type: EXPERIMENTAL
Intervention: Budesonide 9 mg daily for 8 weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 9759800

Group type: EXPERIMENTAL
Intervention: Acetaminophen (paracetamol)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 9
Study: 8588136

Group type: EXPERIMENTAL
Intervention: Ampicillin plus mecillinam (A+M)
Number of subjects: 293

Group type: COMPARATOR
Intervention: Cefotaxime followed by cefadroxil
Number of subjects: 293
Study: 2483445

Group type: EXPERIMENTAL
Intervention: Ibopamine, digitalis, and diuretics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo, digitalis, and diuretics
Number of subjects: 0
Study: 779561

Group type: EXPERIMENTAL
Intervention: 2 ounces of ethanol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 5 ounces of ethanol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Fresca (control)
Number of subjects: 12
Study: 31553471

Group type: EXPERIMENTAL
Intervention: BCG vaccine
Number of subjects: 2963

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2963
Study: 28698169

Group type: EXPERIMENTAL
Intervention: Digital medicine offering (DMO) for 4 weeks
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Digital medicine offering (DMO) for 12 weeks
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Digital medicine offering (DMO)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 109
Study: 26228887

Group type: EXPERIMENTAL
Intervention: HydroCoils
Number of subjects: 66
Study: 23207715

Group type: EXPERIMENTAL
Intervention: Active stimulation
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 14
Study: 21561620

Group type: EXPERIMENTAL
Intervention: n-3 fatty acids (2.4 g/day of EPA and DHA for 6 weeks)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Combination of statins and n-3 fatty acids
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control (soya and corn oil)
Number of subjects: 43
Study: 18427130

Group type: EXPERIMENTAL
Intervention: Aggressive lipid-lowering strategy
Number of subjects: 1319

Group type: COMPARATOR
Intervention: Moderate lipid-lowering strategy
Number of subjects: 1319

Group type: EXPERIMENTAL
Intervention: Aggressive lipid-lowering therapy
Number of subjects: 1319
Study: 16540826

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Stretching and relaxation program (Control)
Number of subjects: 30
Study: 12370849

Group type: EXPERIMENTAL
Intervention: High-fat diet (HFD)
Number of subjects: 9

Group type: COMPARATOR
Intervention: High-carbohydrate diet (HCD)
Number of subjects: 9
Study: 10325756

Group type: COMPARATOR
Intervention: Once daily growth hormone injections (6 IU/m2/day)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Twice daily growth hormone injections (6 IU/m2/day)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both interventions (once daily and twice daily) with low dose ethinyl oestradiol (0.05 microgram/kg/day, increased to 0.10 microgram/kg/day after 2.25 years)
Number of subjects: 19
Study: 7489218

Group type: EXPERIMENTAL
Intervention: Epidural spinal cord electrical stimulation (ESES) in addition to best medical treatment
Number of subjects: 120

Group type: COMPARATOR
Intervention: Best medical treatment alone
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ESES treatment
Number of subjects: 120
Study: 1844568

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (100 mg per day for 8 weeks)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (100 mg per day for 8 weeks)
Number of subjects: 10
Study: 6786412

Group type: EXPERIMENTAL
Intervention: 5 percent mannitol solution orally
Number of subjects: 38

Group type: COMPARATOR
Intervention: Isotonic saline via nasogastric tube
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Combination of 10 percent mannitol and isotonic saline
Number of subjects: 38
Study: 29554042

Group type: EXPERIMENTAL
Intervention: Leukoreduced whole blood
Number of subjects: 41

Group type: COMPARATOR
Intervention: Nonleukoreduced whole blood
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Agitation methods
Number of subjects: 41
Study: 28024270

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (30mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26306456

Group type: EXPERIMENTAL
Intervention: Antitachycardia pacing (ATP) for slow VT (CL 400-321 ms) and fast VT (CL 250-320 ms)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Antitachycardia pacing (ATP) in secondary prevention (SP) patients
Number of subjects: 67
Study: 23535211

Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Nutritional supplementation (protein/carbohydrate) during RT
Number of subjects: 59
Study: 21632666

Group type: EXPERIMENTAL
Intervention: Very low energy diet for nine weeks (2.3 MJ/day for seven weeks and two weeks of gradual introduction of normal food) followed by a weight loss maintenance programme
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Very low energy diet
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Weight loss
Number of subjects: 63
Study: 18842151

Group type: EXPERIMENTAL
Intervention: Large head metal-on-metal total hip arthroplasty (cementless titanium alloy acetabular component with cobalt-chromium liner and cobalt-chromium femoral head varying from 38 to 60 mm)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 28 mm metal-on-polyethylene total hip arthroplasty (cementless titanium alloy acetabular component with polyethylene liner and 28 mm cobalt-chromium femoral head)
Number of subjects: 0
Study: 17238337

Group type: EXPERIMENTAL
Intervention: Digital pen and paper technology for vital sign data capture
Number of subjects: 0
Study: 12955414

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 2647

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2647
Study: 10626718

Group type: EXPERIMENTAL
Intervention: Midazolam premedication (2 mg im 30 min before operation)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no midazolam premedication)
Number of subjects: 50
Study: 10180649

Group type: EXPERIMENTAL
Intervention: Community optometrists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hospital ophthalmologists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hospital ophthalmologists (assuming 6-month follow-up)
Number of subjects: 0
Study: 8204811

Group type: EXPERIMENTAL
Intervention: Inhalation of nitric oxide (NO) at concentrations of 2 to 25 ppm for 6 to 10 minutes
Number of subjects: 7
Study: 2454375

Group type: COMPARATOR
Intervention: Carvedilol (C)
Number of subjects: 0
Study: 28719485

Group type: EXPERIMENTAL
Intervention: Application of heat gel pack after removal of EMLA cream (treatment group)
Number of subjects: 400

Group type: COMPARATOR
Intervention: No application of heat gel pack (control group)
Number of subjects: 400
Study: 26512967

Group type: EXPERIMENTAL
Intervention: ABCC3
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: ABCG2
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Number of overexpressed ABC-transporters
Number of subjects: 112
Study: 24447534

Group type: EXPERIMENTAL
Intervention: Sildenafil ODT without water (50 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Sildenafil ODT with water (50 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: High-fat meal effect on sildenafil ODT
Number of subjects: 36
Study: 22978684

Group type: EXPERIMENTAL
Intervention: Rituximab-chlorambucil
Number of subjects: 49

Group type: COMPARATOR
Intervention: Rituximab alone
Number of subjects: 49
Study: 19933411

Group type: EXPERIMENTAL
Intervention: Benzbromarone
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 18164862

Group type: EXPERIMENTAL
Intervention: 68 Gy EBRT
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 78 Gy EBRT
Number of subjects: 96
Study: 16896965

Group type: EXPERIMENTAL
Intervention: 2/4‐mg gum + 15‐mg patch (G/P)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 2/4‐mg lozenges + 15‐mg patch (L/P)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Inhaler + 15‐mg patch (I/P)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 10 mg + 15‐mg patches (P/P)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Acute‐patch combinations (A/P)
Number of subjects: 27
Study: 11889328

Group type: EXPERIMENTAL
Intervention: Intravenous salbutamol (15 microg/kg as a single bolus over 10 mins)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Intravenous salbutamol
Number of subjects: 55

Group type: COMPARATOR
Intervention: Ipratropium bromide (250 microg)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Intravenous salbutamol plus ipratropium bromide
Number of subjects: 55
Study: 9620490

Group type: EXPERIMENTAL
Intervention: Cadexomer iodine paste (Iodosorb/Iodoflex)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Hydrocolloid dressing (Duoderm E, Granuflex E)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Paraffin gauze dressing (Jelonet)
Number of subjects: 153
Study: 2654196

Group type: EXPERIMENTAL
Intervention: Digital subtraction images
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Contrast enhanced subtraction images
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Color-converted digital subtraction images
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Re-analysis after 2 months
Number of subjects: 62
Study: 201006

Group type: EXPERIMENTAL
Intervention: RMP (Rifampicin)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: EMB (Ethambutol)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: SM (Streptomycin)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: INH-RMP (Isoniazid and Rifampicin)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: INH-EMB (Isoniazid and Ethambutol)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: INH-SM (Isoniazid and Streptomycin)
Number of subjects: 114
Study: 6452798

Group type: EXPERIMENTAL
Intervention: Zimelidine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 40
Study: 31686770

Group type: EXPERIMENTAL
Intervention: eHealth screening procedure every third month (3M)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: eHealth screening procedure on demand (OD)
Number of subjects: 102

Group type: COMPARATOR
Intervention: eHealth screening procedure (3M)
Number of subjects: 102

Group type: COMPARATOR
Intervention: eHealth screening procedure (OD)
Number of subjects: 102
Study: 28076829

Group type: EXPERIMENTAL
Intervention: Letrozole 2.5mg once daily + Cabergoline 0.5mg/week for 12 weeks
Number of subjects: 88

Group type: COMPARATOR
Intervention: Letrozole alone for 12 weeks
Number of subjects: 88
Study: 27701629

Group type: EXPERIMENTAL
Intervention: Enhanced Conversational Recast treatment (30-min session, massed condition)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Enhanced Conversational Recast treatment (3 sessions of 10-min each, spaced condition)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Enhanced Conversational Recast treatment (both conditions)
Number of subjects: 16
Study: 24201413

Group type: EXPERIMENTAL
Intervention: Dexketoprofen trometamol (Group A)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo (Group P)
Number of subjects: 150
Study: 22494344

Group type: EXPERIMENTAL
Intervention: Explanations provided for the events in the decision task
Number of subjects: 0

Group type: COMPARATOR
Intervention: No explanation provided for the events in the decision task
Number of subjects: 0